Taysha Gene Therapies, Inc.TSHANASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank67
3Y CAGR-1.8%
5Y CAGR+22.1%
Year-over-Year Change
Research and development spending
3Y CAGR
-1.8%/yr
Annual compound
5Y CAGR
+22.1%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $86.40M | +30.9% |
| 2024 | $66.00M | +16.2% |
| 2023 | $56.78M | -37.7% |
| 2022 | $91.17M | -30.9% |
| 2021 | $131.94M | +313.7% |
| 2020 | $31.89M | +3131.3% |
| 2019 | $987000.00 | - |